Skip to main content
. Author manuscript; available in PMC: 2021 Feb 8.
Published in final edited form as: J Nanosci Nanomed. 2020 Feb 3;4(2):1–9.

Figure 11).

Figure 11)

Flow cytometric evaluation of the binding of P2K (PEG 2K-conjugated pertuzumab) with HER-2 over-expressing SKBR3 cells compared to pure (unmodified) antibodies (trastuzumab (TMAB) and pertuzumab (PMAB)). Tube_018_001.fcs (Human IgG1 isotype control (the nonbinding antibody control)